Efficacy of a Lipolytic Cream in an Overweight and Obesity Treatment
Primary Purpose
Lipolysis, Overweight and Obesity, Diet Modification
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Dr.K. Treatment
Sponsored by

About this trial
This is an interventional treatment trial for Lipolysis focused on measuring obesity, overweight, fat percentage, body fat, lipolytic cream
Eligibility Criteria
Inclusion Criteria:
- Overweight and obesity treatment voluntary assistance
Exclusion Criteria:
- Hearth disease
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
LC
NLC
Arm Description
Lypolitic cream with hypocaloric diet and physicial activity in 51 patients
Hypocaloric diet and physicial activity alone in 51 patients
Outcomes
Primary Outcome Measures
Change in body composition with a scientific impedanciometer
Body fat in kilograms and percentage variation measured with an impendaciometer (Tanita MC780)
Secondary Outcome Measures
Change in perimeters measured with measuring tape
Variation in the perimeters in centimeters in waist, hip, thigh and arm.
Full Information
NCT ID
NCT03721185
First Posted
September 24, 2018
Last Updated
October 24, 2018
Sponsor
BiomediKcal
Collaborators
University of Alicante, Universidad Miguel Hernandez de Elche, Universidad Simón Bolívar
1. Study Identification
Unique Protocol Identification Number
NCT03721185
Brief Title
Efficacy of a Lipolytic Cream in an Overweight and Obesity Treatment
Official Title
Efficacy of a Lipolytic Cream in the Body Composition of an Overweight and Obesity Treatment
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
June 1, 2016 (Actual)
Primary Completion Date
September 21, 2018 (Actual)
Study Completion Date
September 23, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
BiomediKcal
Collaborators
University of Alicante, Universidad Miguel Hernandez de Elche, Universidad Simón Bolívar
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The coadyouvant efficacy of a combination of cosmetics ingredients in the form of a lipolytic cream with hypocaloric diet and physical activity were assessed and compared with with hypocaloric diet and physical activity for overweight and obesity treatment in patients.
Detailed Description
The coadyouvant efficacy and safety of a combination of cosmetics ingredients in the form of a lipolytic cream with hypocaloric diet and physical activity were assessed and compared with with hypocaloric diet and physical activity for overweight and obesity treatment in patients of both gender and different age groups. DESIGN: In a monocenter, open-label, randomized, parallel-group study of 102 patients that consulted for overweight and obesity treatment were analyzed in perimeters and body composition for 12 consecutive weeks that were medically prescribed a weekly hypocaloric diet and physical activity for one group of 51 patients, and hypocaloric diet, physical activity and the lypolitic cream at least twice per day for the other group of 51 patients. Efficacy was evaluated by comparing intial and final of all values in both groups. Safety was monitored by the incidence of adverse events. Patients also assessed the acceptability of the cream presentation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lipolysis, Overweight and Obesity, Diet Modification, Physical Activity
Keywords
obesity, overweight, fat percentage, body fat, lipolytic cream
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
open-label, randomized, parallel-group
Masking
None (Open Label)
Masking Description
Researchers assessed the efficacy of a lipolytic cream with hypocaloric diet and physical activity in the treatment of overweight and obesity. The control treatment was lypolitic cream with hypocaloric diet and physicial activity and hypocaloric diet and physicial activity alone. In total, 102 patients were recruited and allocated to treatment (51: lypolitic cream with hypocaloric diet and physicial activity and, 51: hypocaloric diet and physicial activity alone.
Allocation
Randomized
Enrollment
102 (Actual)
8. Arms, Groups, and Interventions
Arm Title
LC
Arm Type
Active Comparator
Arm Description
Lypolitic cream with hypocaloric diet and physicial activity in 51 patients
Arm Title
NLC
Arm Type
Placebo Comparator
Arm Description
Hypocaloric diet and physicial activity alone in 51 patients
Intervention Type
Combination Product
Intervention Name(s)
Dr.K. Treatment
Intervention Description
Overweight and obesity treatment response
Primary Outcome Measure Information:
Title
Change in body composition with a scientific impedanciometer
Description
Body fat in kilograms and percentage variation measured with an impendaciometer (Tanita MC780)
Time Frame
Baseline and weeks: 1, 4, 8, 12,16
Secondary Outcome Measure Information:
Title
Change in perimeters measured with measuring tape
Description
Variation in the perimeters in centimeters in waist, hip, thigh and arm.
Time Frame
Baseline and weeks: 1, 4, 8, 12,16
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Overweight and obesity treatment voluntary assistance
Exclusion Criteria:
Hearth disease
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymous patient information will be shared only if requested and justified in writing by researchers. It will be evaluated in committee if it is a justified request.
Citations:
PubMed Identifier
26082579
Citation
Byun SY, Kwon SH, Heo SH, Shim JS, Du MH, Na JI. Efficacy of Slimming Cream Containing 3.5% Water-Soluble Caffeine and Xanthenes for the Treatment of Cellulite: Clinical Study and Literature Review. Ann Dermatol. 2015 Jun;27(3):243-9. doi: 10.5021/ad.2015.27.3.243. Epub 2015 May 29.
Results Reference
result
PubMed Identifier
21284660
Citation
Escudier B, Fanchon C, Labrousse E, Pellae M. Benefit of a topical slimming cream in conjunction with dietary advice. Int J Cosmet Sci. 2011 Aug;33(4):334-7. doi: 10.1111/j.1468-2494.2010.00630.x. Epub 2011 Feb 1.
Results Reference
result
PubMed Identifier
17441853
Citation
Salavert M, Amarger S, Le Bouedec MC, Roger H, Souteyrand P, D'incan M. Allergic contact dermatitis to guggul in a slimming cream. Contact Dermatitis. 2007 May;56(5):286-7. doi: 10.1111/j.0105-1873.2006.00885.x. No abstract available.
Results Reference
result
Learn more about this trial
Efficacy of a Lipolytic Cream in an Overweight and Obesity Treatment
We'll reach out to this number within 24 hrs